NORADRENALINE (NOREPINEPHRINE) 0.08 mg/ml, solution for infusion
*Company:
Aguettant LtdStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company

Updated on 09 February 2026
File name
Noradrenaline (Norepinephrine) 0.08 mg mL solution for infusion SmPC IE.pdf
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 09 February 2026
File name
Noradrenaline (Norepinephrine) 0.08 mg mL solution for infusion PIL IE.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 11 July 2024
File name
IE PIL Noradrenaline 0.08mg ml vial.pdf
Reasons for updating
- New PIL for medicines.ie
Updated on 11 July 2024
File name
IE SmPC Noradrenaline 0.08mg ml vial.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 29 January 2019
File name
IE DHPC_Noradrenaline_HPRA_clean dated on Jan 2019 signed.pdf
Reasons for updating
- Add New Doc
Updated on 15 January 2019
File name
Noradrenaline0.08_PIL_IE_2016.02.05.pdf
Reasons for updating
- New PIL for new product
Aguettant Ltd

Address:
No 1 Farleigh House, Flax Bourton, Old Weston Road, Bristol , BS48 1UR, UKMedical Information E-mail:
info@aguettant.co.ukTelephone:
+353 (0)143 11350


